News & Press

• Subscribe
• Archive

• 9/1/2010 7:01:46 AM

  Covidien Announces Investor Meeting Agenda

  DUBLIN, Sep 01, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Wednesday, September 15, 2010. The event will be held at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY. A webcast of the presentations will begin at 12:00 pm and the webcast will conclude by 5:00 pm. …

• 8/30/2010 7:01:54 AM

  Covidien Completes Sale of Sleep Therapy Product Line

  DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a privately held company located in Luxembourg. Financial terms of the transaction were not disclosed. …

• 8/30/2010 7:01:54 AM

  Covidien Completes Sale of Specialty Chemicals Business

  DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price of approximately $280 million. …

• 7/30/2010 7:02:02 AM

  Covidien to Present at BMO Capital Markets Conference

  MANSFIELD, Mass., Jul 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference in New York on Thursday, August 5, 2010. José (Joe) Almeida, President, Medical Devices, will represent the company in a session scheduled at 3:30 p.m. ET. …